Inventor
CALDWELL WILLIAM SCOTT
US28 patents
⚠️ This page may combine multiple inventors who share the name “CALDWELL WILLIAM SCOTT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TARGACEPT INC
17 patentsUS6492399B1Dec 10, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC120 citations98
US6274606B1Aug 14, 2001
Methods of treating central nervous system disorders with aryl substituted olefinic amine compounds
TARGACEPT INC46 citations96
US6232316B1May 15, 2001
Methods for treatment of CNS disorders
TARGACEPT INC48 citations96
US6455554B1Sep 24, 2002
Oxopyridinyl pharmaceutical compositions and methods for use
TARGACEPT INC77 citations94
US6958399B2Oct 25, 2005
Compounds capable of activating cholinergic receptors
TARGACEPT INC28 citations92
US6624173B1Sep 23, 2003
Pharmaceutical compositions for treating and/or preventing CNS disorders
TARGACEPT INC39 citations92
US6603011B1Aug 5, 2003
3-pyridinyl compounds
TARGACEPT INC38 citations92
US6555684B2Apr 29, 2003
Pyrimidinyl compounds for treatment of central nervous system disorders
TARGACEPT INC25 citations92
US6531606B1Mar 11, 2003
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
TARGACEPT INC22 citations92
US6525065B1Feb 25, 2003
Pharmaceutical compositions and methods for effecting dopamine release
TARGACEPT INC24 citations92
US6489349B1Dec 3, 2002
Pharmaceutical compositions for inhibition of cytokine production and secretion
TARGACEPT INC31 citations92
US6417359B1Jul 9, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC33 citations92
US6337351B1Jan 8, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC32 citations92
US6310102B1Oct 30, 2001
Pharmaceutical compositions and methods for use
TARGACEPT INC27 citations92
US7307092B2Dec 11, 2007
Compounds Capable of Activating Cholinergic Receptors
TARGACEPT INC9 citations73
US7060826B2Jun 13, 2006
Compounds capable of activating cholinergic receptors
TARGACEPT INC10 citations73
US7790757B2Sep 7, 2010
Compounds capable of activating cholinergic receptors
TARGACEPT INC0 citations51
(unassigned)
10 patentsUS5861423AJan 19, 1999
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
119 citations98
US5824692AOct 20, 1998
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
67 citations96
US5726316AMar 10, 1998
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
98 citations96
US6262124B1Jul 17, 2001
Pharmaceutical compositions and methods for use
22 citations92
US6057446AMay 2, 2000
Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
20 citations92
US5885998AMar 23, 1999
Methods for prevention and treatment of attention deficit disorder
28 citations92
US5731314AMar 24, 1998
Pharamceutical compositions for prevention and treatment of tourette's syndrome
29 citations92
US6107298AAug 22, 2000
Methods for prevention and treatment of Tourette's syndrome and schizophrenia
13 citations74
US6100269AAug 8, 2000
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
5 citations74
US5922723AJul 13, 1999
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
9 citations74